Clinical trials
Lung Diseases, Obstructive clinical trials
Below are recruiting lung diseases, obstructive clinical trials, each written for real people, not researchers. We’re tracking 202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07870655Enrolling by invitation
Long-term effects of exercise habits in COPD
This study looks at how exercise habits from an earlier COPD exercise trial affect patients over the long term. It helps understand if the benefits last and how to keep patients active.
CopenhagenAges 40–80 - NCT06068322Recruiting
Very intense interval training for people with COPD
This study tests whether a very intense, short burst of exercise (supramaximal high-intensity interval training) is safe and effective for people aged 60 and older with or without COPD. It aims to see if this type of exercise can improve fitness and daily life.
Hasselt, DiepenbeekAges 60 years+ - NCT07842510Recruiting
Controlled oxygen for copd flare-ups in the icu
This trial tests whether giving oxygen in a carefully controlled way (using a target range) works better than standard oxygen treatment for people in the ICU with a COPD flare-up. It aims to see if the controlled approach leads to better outcomes, like helping you recover faster.
Mahdia, Mahdia GovernorateAges 40 years+ - NCT07823842Recruiting
Biologics for asthma and COPD
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80 - NCT07780656RecruitingPhase 3
Felcorekibart for chronic obstructive pulmonary disease (COPD)
This study tests a new medicine, felcorekibart, to see if it can reduce COPD flare-ups better than a placebo after 52 weeks. It's designed for people with high eosinophils, a type of white blood cell linked to inflammation.
Miami, FloridaAges 40–80 - NCT07751705Recruiting
Using sound waves to collect lung mucus samples in COPD patients
This trial is testing whether a device that uses sound waves can help collect lung mucus samples more easily in people with COPD. It compares two groups: current smokers and ex-smokers, to see if the device works differently for them.
Hanover, Lower SaxonyAges 40 years+ - NCT07684820RecruitingPhase 2
A study of ExPD-101 for COPD with chronic bronchitis and frequent flare-ups
This study tests an experimental drug (ExPD-101) given daily as a pill for 52 weeks for people with COPD who have chronic bronchitis and frequent flare-ups. It compares the drug to a placebo (inactive pill) to see if it reduces flare-ups and improves symptoms.
Phoenix, ArizonaAges 40–85 - NCT07668518RecruitingPhase 1/Phase 2
Study of KIT2014 for moderate to severe COPD
This trial tests a new medicine called KIT2014 in people with moderate to severe COPD. It aims to see if the drug is safe, tolerable, and helps improve breathing and COPD symptoms.
Charlestown, New South WalesAges 40–80 - NCT07665931Recruiting
Testing Simeox for severe COPD with lung hyperinflation
This trial tests if a device called Simeox can reduce trapped air in the lungs of people with severe COPD. It may help you breathe easier if you have pulmonary hyperinflation.
Codogno, LombardyAges 18 years+ - NCT07640451RecruitingPhase 2
HRS-9821 inhalation treatment for moderate to severe COPD
This trial tests whether an inhaled medication called HRS-9821 can help people with moderate to severe COPD (chronic obstructive pulmonary disease) breathe better and reduce symptoms. You inhale the medication, and researchers will measure how well your lungs work and how you feel over time.
Shanghai, Shanghai MunicipalityAges 40–80 - NCT05730088Recruiting
Helping COPD patients avoid hospital visits with home nursing support
This trial tests whether adding several nursing check-ins and coaching (using home oxygen and regular contact) can help people with severe COPD avoid going back to the hospital. It uses phone or internet tools to support care at home.
KonyaAges 18 years+ - NCT07583849RecruitingPhase 3
Testing a new inhaled powder for COPD symptoms
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
Beijing, Beijing MunicipalityAges 40–80 - NCT06413524Recruiting
Vibration exercises for people with COPD
This trial tests if different types of vibration exercises can help people with COPD (a chronic lung disease). It may be a good fit if you have severe COPD or have had recent flare-ups, are not already exercising regularly, and are willing to try a new therapy.
Taipei, Wenshan DistAges 40–99 - NCT06655428Recruiting
A new treatment for severe emphysema using heat and liquid
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
Vienna, AustriaAges 40 years+ - NCT07441226RecruitingPhase 2
Stem cells for advanced COPD treatment
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
Jakarta, Jakarta Special Capital RegionAges 40–75 - NCT07382986Recruiting
COPD care in China
This study is a long-term patient registry collecting health information from people with COPD (chronic obstructive pulmonary disease) in China. Joining means you will receive regular check-ups and your doctor can track your condition over time, which may help improve management of your disease.
Hebi, HenanAges 40–85 - NCT07351734RecruitingPhase 2
Testing JKN2403 for COPD: a new treatment option
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
Guangzhou, GuangdongAges 40–80 - NCT07307781Recruiting
Study of COPD patients with frequent flare-ups in Moscow
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
MoscowAges 18–100 - NCT07285642Recruiting
Oxygen levels in muscles and brain in COPD patients
This study measures oxygen levels in your brain and leg muscles during exercise to understand how COPD affects them.
IstanbulAges 40–70 - NCT07213128Recruiting
Breathing muscle training after a COPD flare-up
This trial tests whether a special breathing muscle training program, done at home with help from a smartphone app, can help you recover better after a hospital stay for a COPD flare-up.
AalstAges 35 years+ - NCT07195838Recruiting
Mindful breathing for people with COPD
This study tests a mindful breathing program for people with COPD. It aims to help reduce stress and improve breathing. Participants use a smartphone or tablet to take part from home.
Hong KongAges 50–80 - NCT06952881Recruiting
Studying COPD types and treatable traits
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
Hong KongAges 40 years+ - NCT07118306Recruiting
COPD flare-up follow-up study
This study is for people with COPD who go to the emergency room for a moderate or severe flare-up. It looks at how they are doing after their visit and whether their current inhaler treatment is working well.
Park Ridge, IllinoisAges 40 years+
Hear when a new Lung Diseases, Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung diseases, obstructive?
- Yes. Clin2 currently lists 202 recruiting lung diseases, obstructive studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung diseases, obstructive trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung diseases, obstructive trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.